SIO2021 Conference Recordings

SIO2021 Conference Recordings

  • Contains 1 Component(s)

    This recording is part of the SIO2021 Conference Recordings Bundle. (2-6 February 2021) Talks: 939141 Radiologic-Pathologic Analysis of Novel Ethanol Gel Formulation for Percutaneous Ablation in a Rat Liver Model - Erika Chelales; 956873 Image Guidance and Assessment of Histotripsy Ablations Using Cone-Beam CT - Sarvesh Periyasamy; 957284 Prevalence of Goals of Care Discussions and Palliative Care Consultations Prior to Interventional Oncology Procedures - Summer Beeson; 960721 Retrospective Cohort Analysis of an Enhanced Recovery After Procedure (ERAP) Pathway is Associated with Decreased Peri-procedural Opioid Consumption for CT-Guided Liver Microwave Ablation Procedures - Rafael Vasquez; 961918 MWA ablation of T1a and T1b renal cell carcinomas: Prognostic factors affecting the progression survival rates - Evgenia Efthymiou; 961955 Safety, tolerability and efficacy of transarterial chemoembolization using anthracyclines-loaded drug eluting microspheres for the treatment of patients with hepatocellular carcinoma: Pooled Analyses - Filipe Veloso Gomes; 962020 Transarterial chemoembolization for neuroendocrine tumor liver metastases : A 15-year monocentric experience - Caroline Touloupas; 962402 Quantitative ultrasound to guide intraprocedural decision-making: preclinical assessment in a clinically relevant rat liver cancer model Ryosuke Taiji 962566 Quantitative Analysis of Microwave Lung Ablation Zones - Arvind Dev

    This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!

       
    939141 Radiologic-Pathologic Analysis of Novel Ethanol Gel Formulation for Percutaneous Ablation in a Rat Liver Model Erika Chelales
    956873 Image Guidance and Assessment of Histotripsy Ablations Using Cone-Beam CT Sarvesh Periyasamy
    957284 Prevalence of Goals of Care Discussions and Palliative Care Consultations Prior to Interventional Oncology Procedures Summer Beeson
    960721 Retrospective Cohort Analysis of an Enhanced Recovery After Procedure (ERAP) Pathway is Associated with Decreased Peri-procedural Opioid Consumption for CT-Guided Liver Microwave Ablation Procedures Rafael Vasquez
    961918 MWA ablation of T1a and T1b renal cell carcinomas: Prognostic factors affecting the progression survival rates Evgenia Efthymiou
    961955 Safety, tolerability and efficacy of transarterial chemoembolization using anthracyclines-loaded drug eluting microspheres for the treatment of patients with hepatocellular carcinoma: Pooled Analyses Filipe Veloso Gomes
    962020 Transarterial chemoembolization for neuroendocrine tumor liver metastases : A 15-year monocentric experience Caroline Touloupas
    962402 Quantitative ultrasound to guide intraprocedural decision-making: preclinical assessment in a clinically relevant rat liver cancer model Ryosuke Taiji
    962566 Quantitative Analysis of Microwave Lung Ablation Zones Arvind Dev
  • Contains 1 Component(s) Recorded On: 06/01/2022

    SIO2021 Hackathon Winner, Michelle Bardis, MD, PGY1, provides an update on her research (June 2022).

    SIO2021 Hackathon Winner, Michelle Bardis, MD, PGY1, provides an update on her research (June 2022).

  • Contains 1 Component(s)

    This recording is part of the SIO2021 Conference Recordings Bundle. (2-6 February 2021)

    This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!

    <


    MODERATORWilliam Rilling, MD
    MODERATORMatthew Callstrom, MD, PhD
    AI Dovetail with Focuses on IO/IRMichael Muelly, MD
    WearablesBradford Wood, MD
    Treatment Planning & Verification: Learning from the MastersAaron Abajian, MD, MS
    Simulation and GuidancePunit Prakash, PhD
    RoboticsJeff Schlosser, PhD
    Q&AAll Faculty
  • Contains 1 Component(s)

    This recording is part of the SIO2021 Conference Recordings Bundle. (2-6 February 2021)

    This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!


    MODERATORDavid Madoff, MD
    MODERATORSarah White, MD, MS
    Hypoxia and Drug PerfusionRahul Sheth, MD
    Conditioning the Tumor Microenvironment Through TACE for Multiplexed HCC TargetingTerence Gade, MD, PhD
    Tumor Microenvironment and Immune ModulationScott Thompson, MD, PhD
    Q&AAll Faculty
  • Contains 1 Component(s)

    This recording is part of the SIO2021 Conference Recordings Bundle. (2-6 February 2021)

    This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!

    MODERATORDavid Breen, MD, MRCP, FRCR
    MODERATORNaomi Balzer Haas, MD
    T1B Lesions: IR ApproachesTim McClure, MD
    T1B Lesions: Surgeon ApproachesJohn Leppert, MD
    Immunotherapy for Prostate and RCCNaomi Balzer Haas, MD
    IR for Localized & Advanced Prostate CancerDavid Woodrum, MD, PhD
    Addressing Oligometastatic Disease in Prostate and RCCNick Anil Kurup, MD
    957496 Preclinical Validation of Synergistic Local Combination of Radiation and PD-L1 Immunotherapy Using Radiation Responsive Nanocarriers for the Treatment of Prostate CancerDavid Woodrum, MD, PhD
    Q&AAll Faculty
  • Contains 1 Component(s)

    This recording is part of the SIO2021 Conference Recordings Bundle. (2-6 February 2021)

    This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!


     MODERATORLaura Crocetti, MD, PhD, EBIR
    Is Biospy Dead in the Era of LIRADS? Claude Sirlin, MD
    Changing landscape of systemic therapy for HCC Robin Kate Kelley, MD
    Transplantation Triage Andy Bonham, MD
    Transarterial Therapies for HCC: Have We Reached Consensus?/Personalized Dosimetry for Y90 Dave Liu, MD
    Is SABR Definitive Treatment for HCC? Laura Dawson, MD
    Is Ablation Definitive Treatment for HCC? Laura Crocetti, MD, PhD, EBIR
    957019 Delayed Treatment Response after Radiation Segmentectomy: Is 3 months follow up enough? Shanmukha Srinivas, MD
    Q&AAll Faculty
  • Contains 1 Component(s)

    This recording is part of the SIO2021 Conference Recordings Bundle. (2-6 February 2021)

    This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!


     MODERATORJohn Louie, MD
    MODERATORFranco Orsi, MD
    Liver Dominant Neuroendocrine DiseaseJohn Louie, MD
    Metastatic MelanomaBrian Stedman, MD
    Metastatic BreastFranco Orsi, MD
    Metastatic GYNDamian Dupuy, MD
    Metastatic Prostate and KidneyEric Hohenwalter, MD, FSIR
    Q&AAll Faculty
  • Contains 1 Component(s)

    This recording is part of the SIO2021 Conference Bundle. (2-6 February 2021)

    This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!

     MODERATORJulius Chapiro, MD, PhD
    Ethiodol as a Bio Marker Julius Chapiro, MD, PhD
    Cost Effectiveness and Advanced Imaging Nishita Kothary, MD
    Hepatic Lymphorrhea: Access and Treatment Masanori Inoue, MD
    Q&A All Faculty
  • Contains 1 Component(s)

    This recording is part of the SIO2021 Conference Recordings Bundle. (2-6 February 2021)

    This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!

     MODERATORKevin Kim, MD
    Current state of Immunotherapy for HCC Bruno Sangro, MD, PhD
    Immunotherapy with Immunotherapy (ie better results when IOs are combined with other IOs) Masatoshi Kudo, MD
    Immunotherapy and Its Current Place in Practice Guidelines Riccardo Lencioni, MD, FSIR, EBIR
    Immunotherarpy combined with Interventional Oncology: What is the current state? Tim Greten, MD
    Q&A All Faculty
  • Contains 1 Component(s)

    This recording is part of the SIO2021 Conference Recordings Bundle. (2-6 February 2021)

    This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!


     MODERATORPhilippe Pereira, MD
    MODERATORJoe Erinjeri, MD, PhD
    Immunotherapy OverviewMillie Das, MD
    Intratumoral Injection
    Mikhail Silk, MD
    Ablation & Immunotherapy Rahul Sheth, MD
    Response Assessment Antonia Digklia, MD
    Adoptive T-cell Therapy Kevin Kim, MD, FSIR
    961548 In-depth analysis of immune responses following cryoablation in Melanoma Chakradhar Yakkala, PhD
    961961 Characterization of local and abscopal immune responses generated by histotripsy focused ultrasound tumor ablation Reliza McGinnis
    Q&AAll Faculty